Bonaventure Equity
Overview
Bonaventure Equity is a venture capital firm that invests in early-stage life sciences companies, with a focus on breakthroughs in the cannabis economy, biotech, healthcare, agricultural technology, and psychedelic therapies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gardia | Feb 2026 | Series A | Co-investor |
| LeafWorks | Feb 2020 | Series A | Lead |
| FloraWorks | Jun 2023 | Series A | Lead |
| tCheck | Mar 2022 | Follow-on Offering | Lead |
| Nalu Bio | Feb 2023 | Series A | Co-investor |
Key People
Ross O'Brien
Founder & Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bonaventure Equity based?
Bonaventure Equity is headquartered in Raleigh, North Carolina, United States.
When was Bonaventure Equity founded?
Bonaventure Equity was founded in 2014.
How many portfolio companies does Bonaventure Equity have?
Bonaventure Equity has 5 portfolio companies in Caplight's dataset.
What are some companies in Bonaventure Equity's portfolio?
Portfolio companies visible on Caplight include Gardia, LeafWorks, FloraWorks, tCheck, Nalu Bio.
What was Bonaventure Equity's most recent investment shown here?
Bonaventure Equity's most recent investment in this portfolio sample was in Gardia in 2026.
What sectors does Bonaventure Equity focus on?
Bonaventure Equity focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Bonaventure Equity focus on?
Bonaventure Equity typically invests at the Early stage.